Search results
- It is estimated that 4,000 women will be recalled for new smears after all the tests are checked again.
www.bbc.co.uk/news/uk-northern-ireland-67427562Cervical screening: More than 300 smear tests to be checked ...
People also ask
When is cervical screening recalled?
Will smears be re-checked?
Why were 4,000 women recalled for a new smear?
How many cervical smear tests have been re-checked?
When does a test stop being recalled?
Are vault smears valid screening results?
Oct 26, 2023 · The Southern Trust says it expects to recall around 4,000 women for a new smear test after it reviews 17,368 historic slides.
- Cervical screening: More than 300 smear tests to be checked ...
It is estimated that 4,000 women will be recalled for new...
- Cervical screening: More than 300 smear tests to be checked ...
- Introduction
- Legal Basis For Cervical Screening
- Programme Governance
- Information Governance Principles
- Informed Choice and Consent
- Eligibility and Inclusion Criteria
- Call and Recall Process
- Prior Notification Lists
- Invitations, Reminders and Non Responders
- Sample Requests
1.1 Background
This document is a comprehensive revision of the NHS Cervical Screening Programme (NHS CSP) Good Practice Guide No.18, ‘Cervical screening call and recall: a guide to administrative good practice’ and replaces the version dated 2017. It must be read in conjunction with the NHS cervical screening programme service specification. All documents relating to the management of cervical screening in England are on the GOV.UKwebsite.
1.2 Screening target population
Cervical screening is for women and people with a cervix. The programme sends screening invitations to people with a cervix who are registered as ‘female’ or ‘indeterminate’ at the following ages and intervals. Age 24.5: first invitation (invitations to first screen are issued at 24.5 years). Ages 25 to 49: 3-yearly screening. Ages 50 to 64: 5-yearly screening. Ages 65 plus: screening of those who have not been screened since age 50, or those who have not yet met the criteria to be ceased fro...
1.3 Target audience for this document
This document is intended for those involved in the commissioning, management, governance, delivery and quality assurance of cervical screening call and recall services. This includes: 1. call and recall service providers including managers and staff 2. local screening and immunisation teams (SITs), including screening and immunisation leads (SILs) 3. NHS primary care commissioners 4. NHS public health commissioners 5. Public Health England (PHE) Screening Quality Assurance Service (SQAS) tea...
The Secretary of State for Health and Social Care (SSFH) has a responsibility to protect the health of the public by providing population screening programmes. This responsibility is defined under Section 2 of the National Health Service Act 2006 as amended by Part 1 Section 11 of the Health and Social Care Act 2012. The SSFH delegates the responsi...
3.1 Public Health England, NHS England and NHS Improvement responsibilities
The Immunisation and Screening National Delivery Framework and Local Operating Model defines the governance structures for screening programmes in England. This includes the roles and responsibilities of the various national and local bodies involved in the commissioning, delivery and oversight of local programmes. A diagram showing high level programme governance is available. Under these arrangements, PHEholds responsibility for the national co-ordination and oversight of the screening prog...
3.2 Provider responsibilities
Providers of all operational aspects of call and recall should have a comprehensive quality management system (QMS) in place including standard operating procedures and detailed work instructions that are maintained in line with national guidance. They must contain clear instructions regarding the operational processes in place to enable the safe delivery of the service in line with the agreed standards as set out within the contract with NHS England and NHS Improvement. The QMSshould include...
3.3 Communication and engagement
The call and recall service is a main component of the patient pathway. Local programme boards should ensure all parties are aware of both national and local developments. Attendance at these programme boards is a requirement of the service. A further requirement is linking with education providers for sample taker training. The call and recall service should provide resources such as presentation slides or staff to deliver call and recall aspects of sample-taker training and engage with trai...
4.1 Records management and retention of records
Records management must comply with the latest version of the Records management code of practice for health and social carepublished by NHS Digital. This sets out responsibilities and high-level document retention schedules. The electronic records in the call and recall IT systems constitute the primary or master electronic record for the NHS CSP. They are fundamental to the efficient operation of the service, to the assurance of quality and safety, and for the longer-term evaluation and dev...
4.2 Processing data for call and recall
The NHS CSPprocesses demographic data from GP registration IT systems. This data underpins the operational work of the programme including: 1. initial invitations for screening 2. recall invitations at set periods 3. sending results 4. invitations for follow up investigations where necessary 5. quality assuring the safety and effectiveness of the programme 6. long-term evaluation of the safety and effectiveness of the programme Contracts must be in place and agreed between organisations runni...
4.3 Maintenance of the Section 251 agreement
To maintain S251 approval, PHE must be able to demonstrate to the CAGthat appropriate information governance safeguards are in place for all organisations that provide cancer screening services. Many of these safeguards are standard controls mandated by the NHS and enforced through the commissioning process and standard contracts for providers. PHE complies with the CAG’s required controls through its adherence to the Data Security and Protection Toolkit (DSPT) standards. Organisations provid...
5.1 Approach to consent
The cervical screening programme aims to maximise coverage and uptake among the eligible population. Individuals are supported to make an informed choice about whether to participate. Comprehensive information material is issued with (or signposted in) every screening invitation and for any follow-up procedure. Individuals who choose to attend for screening are considered to have provided consent to be screened and to have consented to the data processing necessary to provide a safe and effec...
5.2 Opting out of screening
Most individuals who choose not to participate in the programme will do so by not making an appointment to have a sample taken rather than by making a request to be ceased. Where individuals do not respond to a screening invitation, they are designated as ‘non-responders’ after 32 weeks and may receive additional reminder letters from their GP practice. Individuals who remain eligible for screening are recalled at intervals according to current protocols. An individual can make an informed ch...
5.3 Objecting to data processing
People have a right to request that their data is no longer processed in the screening programme, however not all data can be removed (see section 17 of the General Data Protection Regulations). Processing personal information is necessary to deliver a safe and effective screening service and is required even if a person has opted out of screening. Historical data held by NHS organisations may need to be retained (for example in case there is an incident and an affected individual needs to be...
6.1 Eligibility for NHS care
Individuals must be eligible for NHS care to also be eligible for cervical screening. Further information can be found on the NHS.UKwebsite.
6.2 Residency
To be eligible for screening under the English programme, individuals must have their primary residence in England. This is consistent with policy in Wales and Scotland which is to screen by resident population (often determined by postcode) along the borders. For practical purposes, the address used for GP registration is used as the primary address. However, for individuals not currently registered with a GP practice, the last available address must be used unless it is known that they have...
6.3 Age
The NHS CSP sends the first invitation for cervical screening when individuals reach the age of 24.5. Individuals are recalled every 3 years until they turn 50, when the recall interval changes to every 5 years. Automatic recall stops when the next test due date (NTDD) is on or after their 65th birthday.
7.1 Summary
The call and recall process uses demographic information from NHS systems (currently NHAIS). When individuals reach the age of 24.5, their details are automatically included on the call and recall system and an initial next test due date (NTDD) is calculated. This means they can be invited for screening. The NTDDis a target date for a person to have a cervical sample taken. Call and recall runs a process to identify those individuals who have a NTDD within the following 10 weeks. A prior noti...
7.2 Calculating next test due date
Individuals are set a NTDD in preparation for their initial screening invitation. Subsequent NTDDsare calculated from the result and action code of their NHS screening tests.
7.3 Routine recall intervals
Routine recall intervals are determined by PHE. Current policy is outlined below. Age under 24.5: no invitation. Age 24.5: eligible for screening, and first invitation issued (to ensure screening test can be completed by their 25th birthday). Age 25 to 49: recall every 3 years (with invitations issued 34.5 months after previous test). Age 50 to 64: recall every 5 years (with invitations issued 58.5 months after previous test). Age 65-plus: invitation as required for individuals who have had r...
8.1 Overview
GP practices have a responsibility to provide assurance that the right individuals are being offered screening. This is managed through the prior notification list (PNL) process. The PNLis a list of individuals from the GP practice who are due to be called or recalled for screening. This provides an opportunity for practice staff to consider deferral or ceasing of individuals if appropriate. Call and recall must send all PNL lists to GP practices 70 days prior to the individuals’ NTDDs. The p...
8.2 Deferring screening
GPs may defer an individual’s screening invitation for a limited number of reasons through the PNL process. Any deferral must specify a reason. The identified reason is used to recalculate the NTDD based on the length of the deferral. Section 5 of the guidance Cervical screening: removing women from routine invitationsdescribes the valid reasons for deferral in detail.
9.1 Invitation and reminder letters
All eligible individuals must receive a written invitation to attend for screening together with the national information leaflet (or a link to the information online) to enable them to make an informed choice about attending. Call and recall issues screening invitations up to 6 weeks before a person’s NTDD. A delay of several months may occur between a person receiving their invitation and booking their screening test. Sending invitations well before a NTDD reduces the chance that someone wi...
9.2 Failsafe process for newly registered individuals
If the individual’s screening history has not been received by call and recall within 21 days of registering in England, a ‘failsafe’ NTDDis set. This is calculated within the current systems to be 91 days (13 weeks) from the date of registration. If the screening history is received after this failsafe NTDD is set and before invitation letters are created, the correct NTDDshould be calculated and set in the system and the GP practice notified. If the individual’s screening history is receive...
9.3 Local content in letters
National invitation letter templates allow up to 5 lines of additional text to be added to provide locally relevant information. Each line can be up to 76 characters per line including spaces and punctuation. Additional text must be clear, factual and of direct relevance to the screening programme. It should also match the existing overall letter style. Standard letters can include an additional paragraph of free text specific to a GP practice. Any GP requiring practice-level text should requ...
10.1 HMR101 request forms
All screening samples must be submitted to the laboratory together with a suitable test request form which has been completed legibly and in full. The HMR101 is the national standard request form for cervical screening. It includes all essential data fields necessary to support patient identification and reporting. Sample takers may use locally-produced versions if these include all standard HMR101 data fields as a minimum. The HMR101 (2009 version) available from the Open Exetersystem is pre...
Sep 27, 2024 · People referred to colposcopy following a screening test are automatically recalled for a follow-up screening test 12 months after the date of their previous test as a failsafe measure.
- This document gives information about the appropriate use of ceasing and deferring in the NHS Cervical Screening Programme.The programme invites el...
- 2.1 Ceasing as a result of informed personal choiceThe NHS offers cervical screening using the principle of informed personal choice. All screening...
- 3.1 Ceasing due to ageThe following people are eligible to receive a screening invitation while under the age of 25: women, or people with a cervix...
- 4.1 Authority to request ceasingMost ceasing requests are communicated to call and recall directly from a person’s GP practice, either by ad hoc re...
- Different organisations within the screening programme have a number of specific responsibilities. 6.1 GP practiceThe GP practices: check PNLs and...
- 7.1 Retention of documentsPaper documents or electronic files which relate to ceasing must be kept in a secure and accessible location for as long...
Nov 15, 2023 · It is estimated that 4,000 women will be recalled for new smears after all the tests in the major review are re-checked
Jun 24, 2024 · The new NHS Cervical Screening Management System (CSMS) is now live. It replaces the previous call/recall IT system and is now accessed via an NHS smartcard. The Open Exeter system is no longer accessible for the purposes of delivering NHS Cervical Screening Programme services.
Dec 11, 2023 · The report recommended that women considered most at risk should be recalled so they can be reassured by a negative HPV test.
Jun 26, 2024 · The NHS Cervical Screening Management System is live and accessed via an NHS Smartcard. It has replaced the previous call/recall IT system, Open Exeter, which is no longer accessible for the purposes of delivering NHS Cervical Screening Programme services.
